Revive Therapeutics Ltd (RVVTF)

[tcm55]

It seems that data through 4 weeks from starting a patient dosing will initially be what this CT is set for, 28 days.
The 'study' then has 6 week and 8 week data collection that may be 'significant'. Are these results somehow to be included in the Trial records ? Maybe at least be a part of any FDA applications?
IMO, they are Smart putting some longer term data results as important.
Long-haulers and latent damage to the Lungs.?. Certainly a relevant issue....GLTA...


"Following completion of the treatment course, follow up assessments will be performed by a study nurse 14, 28, 42, and 60 days following the end of treatment."
"Up to 1000 patients will be enrolled in this study. Patients will participate in the study approximately 45 days".

https://clinicaltrials.gov/ct2/show/NCT04504